AQR Capital Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $943K | Buy |
70,650
+48,514
| +219% | +$648K | ﹤0.01% | 2239 |
|
|
2025
Q1 | $226K | Buy |
+22,136
| New | +$226K | ﹤0.01% | 2824 |
|
|
2023
Q3 | – | Sell |
-11,441
| Closed | -$460K | – | 2344 |
|
|
2023
Q2 | $460K | Buy |
11,441
+3,850
| +51% | +$155K | ﹤0.01% | 1813 |
|
|
2023
Q1 | $324K | Buy |
+7,591
| New | +$324K | ﹤0.01% | 1924 |
|